prohibitin
phb
scaffold
protein
modul
mani
signal
pathway
control
cell
surviv
metabol
inflamm
sever
drug
target
phb
identifi
evalu
variou
clinic
applic
preclin
clinic
studi
indic
phb
ligand
may
use
oncolog
cardiolog
neurolog
well
obes
review
cover
physiolog
role
phb
health
diseas
current
develop
concern
phb
ligand
formerli
known
homolog
formerli
rea
prohibiton
pleiotrop
protein
multipl
function
initi
identifi
mcclung
collabor
screen
potenti
tumor
suppressor
antiprolif
activ
highli
express
normal
rest
regener
rat
liver
mcclung
et
al
nuell
et
al
phb
sinc
shown
act
hub
mani
signal
pathway
trigger
growth
factor
immun
respons
steroid
hormon
regul
metabol
mitochondri
biogenesi
cell
migrat
divis
surviv
phb
compos
ntermin
transmembran
domain
evolutionarili
conserv
phb
domain
common
scaffold
protein
includ
stomatin
flotillin
hflkc
ctermin
coiledcoil
domain
involv
interact
figur
avail
onlin
although
structur
phb
solv
winter
et
al
abl
gener
structur
model
human
phb
base
known
structur
belong
famili
membran
protein
locat
mitochondri
inner
membran
interact
form
heterodim
organ
ringlik
structur
diamet
nm
figur
back
et
al
coat
et
al
supercomplex
maintain
structur
mitochondria
regul
function
tatsuta
et
al
phb
protect
newli
import
protein
degrad
maaa
mitochondri
atpas
associ
divers
cellular
activ
proteas
steglich
et
al
promot
mitochondri
protein
synthesi
maintain
organ
copi
number
mitochondri
dna
mtdna
kasashima
et
al
act
chaperon
newli
synthes
protein
mitochondri
complex
nijtman
et
al
gtpase
optic
atrophi
mitochondri
fission
morphogenesi
merkwirth
et
al
also
interact
adaptor
protein
major
mediat
stressinduc
apoptosi
madireddi
adaptor
protein
activ
uvc
h
reactiv
oxygen
speci
ro
induc
gener
ro
mitochondria
lead
apoptosi
gertz
et
al
remain
unclear
whether
modul
proapoptot
respons
nevertheless
tempt
specul
involv
cytoprotect
activ
phb
ligand
particularli
oxid
stress
bernard
et
al
fahrig
et
al
kathiria
et
al
liu
et
al
ribeiro
et
al
also
regul
second
messeng
control
divers
physiolog
process
sever
target
bind
high
affin
therebi
maintain
integr
mitochondri
respir
machineri
strub
et
al
process
involv
precondit
protect
heart
ischemiareperfus
injuri
phb
limit
mitochondria
also
found
nucleu
endoplasm
reticulum
plasma
membran
macrophag
phagosom
garin
et
al
modul
mani
aspect
cell
physiolog
role
extrem
complex
partli
phb
regul
sever
tyrosin
serin
phosphoryl
oglcnac
modif
palmitoyl
transamid
tyrosin
nitrosyl
interact
physic
second
messeng
interact
and
mishra
strub
et
al
posttransl
modif
phb
substanti
effect
activ
figur
one
bestdocu
exampl
akt
phosphoryl
block
interact
facilit
akt
signal
and
mishra
phosphatas
facilit
akt
signal
enhanc
insulin
signal
addit
phosphoryl
necessari
activ
craf
ra
chiu
et
al
rajalingam
et
al
establish
activ
craf
ra
requir
heterodimer
craf
phosphoryl
plasma
membran
cancer
cell
activ
akt
craferk
pathway
promot
prolifer
metastasi
chiu
et
al
contrast
insulinreceptorinduc
phosphoryl
promot
heterodimer
phosphatas
block
akt
signal
and
et
al
suggest
regul
transform
growth
factor
b
tgfb
respons
dual
effect
cytokin
prostat
cancer
zhu
et
al
earli
stage
tumorigenesi
tgfb
act
tumor
suppressor
subsequ
promot
metastat
spread
cancer
progress
bind
tgfb
receptor
trigger
crafmekerk
pathway
also
activ
smad
smad
therebi
caus
opposit
effect
figur
erk
activ
protein
kinas
c
pkcd
lead
phosphoryl
consequ
cell
surviv
invas
howev
smad
signal
also
upregul
protein
inhibit
pkcd
lead
hypophosphoryl
promot
apoptosi
activ
regul
serin
threonin
phosphoryl
particular
ross
et
al
sun
et
al
calciumcalmodulindepend
protein
kinas
iv
camkiv
phosphoryl
imped
abil
repress
transcript
activ
myocyt
enhanc
factor
sun
et
al
consequ
phosphoryl
activ
transcript
factor
report
also
inhibit
circadian
transcript
interact
casein
kinas
kategaya
et
al
phb
detect
surfac
platelet
microgli
cell
wintachai
et
al
endotheli
cell
adipos
tissu
kolonin
et
al
paclitaxelresist
cancer
cell
patel
et
al
intestin
epitheli
cell
sharma
qadri
activ
cell
yurugi
et
al
platelet
interact
directli
proteaseactiv
receptor
promot
platelet
aggreg
zhang
et
al
mitochondri
inner
membran
organ
ringlik
structur
maintain
structur
regul
function
mitochondria
interact
maaa
proteas
stomatinlik
protein
atpas
famili
aaa
domaincontain
protein
mtdna
physiolog
role
surfac
microgli
cell
endotheli
cell
adipos
tissu
remain
elus
demonstr
surfac
cancer
cell
involv
resist
paclitaxel
patel
et
al
virul
antigen
salmonella
typhi
caus
agent
typhoid
interact
surfac
intestin
epitheli
cell
result
downregul
mitogenactiv
protein
kinas
mapk
cascad
inhibit
earli
inflammatori
respons
patel
et
al
similarli
consider
proport
total
locat
surfac
activ
cell
contribut
activ
erk
induc
cell
activ
yurugi
et
al
also
present
human
serum
embed
lipid
droplet
interact
complement
protein
promot
innat
immun
mishra
et
al
interestingli
serum
concentr
found
significantli
elev
patient
colorect
cancer
suggest
may
serv
biomark
type
cancer
mengwass
et
al
brief
present
interact
phb
protein
provid
tabl
list
put
partner
see
tabl
involv
growth
resist
chemotherapi
metastasi
sever
mechan
includ
activ
rascrafmekerk
pathway
modul
tgfb
signal
transcript
regul
inde
interact
transcript
factor
nucleu
cancer
cell
increas
transcript
activ
fusaro
et
al
tumor
suppressor
control
cell
cycl
apoptosi
genom
stabil
angiogenesi
chander
et
al
chander
et
al
fusaro
et
al
joshi
et
al
compon
ubiquitin
ligas
complex
overexpress
mani
breast
cancer
interact
promot
degrad
chander
et
al
chander
et
al
umanskaya
et
al
act
activ
fusaro
et
al
chaperon
chander
et
al
deplet
lead
attenu
activ
cancer
cell
overexpress
consequ
promot
surviv
also
import
regul
retinoblastoma
tumor
suppressor
protein
rb
famili
member
wang
et
al
protein
bind
inhibit
transcript
factor
lead
cellcycl
arrest
repress
activ
transcript
factor
interact
sever
protein
includ
rb
histon
deacetylas
hdac
nucleosomeremodel
protein
brm
wang
et
al
wang
et
al
wang
et
al
grow
bodi
evid
indic
cellular
local
phb
determin
function
especi
cancer
cell
patel
et
al
found
overexpress
surfac
cancer
cell
resist
taxoid
doxorubicin
etoposid
also
demonstr
redirect
cytoplasm
cell
surfac
critic
drug
resist
work
suggest
cellsurfac
may
serv
biomark
chemoresist
cancer
patient
normal
epitheli
breast
cell
locat
primarili
mitochondria
invas
noninvas
breast
cancer
cell
mainli
confin
nucleu
suggest
local
phb
integr
mani
signal
pathway
eg
akt
crafmekerk
camk
pkc
orchestr
variou
aspect
cell
physiolog
includ
metabol
transcript
apoptosissurviv
cytoskeleton
reorgan
differenti
izat
associ
tumorigenesi
confoc
microscopi
experi
demonstr
phb
coloc
protooncogen
cmyc
cfo
rb
neuroblastoma
sknsh
cell
treatment
anticanc
drug
camptothecin
lead
export
nucleu
mitochondria
breast
cancer
cell
line
fusaro
et
al
camptothecininduc
transloc
depend
protein
transport
occur
preferenti
transform
cell
line
untransform
primari
cell
peptid
correspond
nuclear
export
signal
prevent
export
result
protect
cell
apoptosi
indic
transloc
nucleu
mitochondria
contribut
tumorsuppress
effect
rastogi
et
al
one
mechan
intracellular
locat
phb
control
involv
signal
protein
trap
cytoplasm
consequ
stimul
estrogensign
pathway
hormonerel
growth
breast
cancer
cell
kim
et
al
beyond
activ
phb
protein
utr
messeng
rna
mrna
found
suppress
prolifer
human
breast
cancer
cell
vitro
growth
breast
tumor
xenograft
mice
vivo
manjeshwar
et
al
first
demonstr
rna
molecul
function
tumor
suppressor
human
breast
cancer
tumorsuppressor
activ
mrna
utr
support
discoveri
oncogen
upregul
mani
cancer
chhabra
et
al
target
utr
downregul
human
gastric
adenocarcinoma
liu
et
al
fletcher
et
al
demonstr
upregul
androgen
receptor
prostat
cancer
result
reduc
mrna
protein
level
increas
cancer
cell
growth
interestingli
ad
cell
overexpress
block
growth
demonstr
oncogen
activ
strongli
involv
signal
prostat
cancer
import
question
need
examin
phb
display
antiand
protumorigen
role
cancer
summar
tabl
dichotomi
may
reflect
heterogen
cancer
cell
type
manifest
alter
differ
signal
pathway
consequ
regul
transcript
translat
posttransl
modif
phb
probabl
depend
cancer
cell
type
involv
posttransl
event
eg
phosphoryl
sumoyl
oglcnac
modif
palmitoyl
transamid
modul
subcellular
local
phb
downstream
effect
prolifer
surviv
cell
cell
surfac
promot
chemoresist
inner
face
plasma
membran
contribut
oncogen
activ
craf
howev
tempt
specul
nucleu
display
antitumorigen
activ
due
action
rb
compon
mammalian
replic
machineri
addit
studi
requir
deciph
role
play
signal
intracellular
local
phb
oncogenesi
mani
studi
indic
phb
protect
cell
oxid
stress
due
excess
product
impair
elimin
ro
jone
close
associ
mitochondri
dysfunct
import
compon
etiolog
cancer
inflammatori
cardiovascular
neurodegen
diseas
diabet
mellitu
view
central
role
phb
maintain
normal
structur
function
mitochondria
unsurpris
phb
allevi
deleteri
effect
oxid
stress
mani
stress
particular
oxid
stress
upregul
promot
cell
surviv
inde
express
enhanc
neuron
variou
stress
includ
electr
stimul
hypoxiaischemia
oxygenglucos
depriv
zhou
et
al
exerciseinduc
neuroplast
ding
et
al
inject
neurotoxin
park
et
al
schizophreniainduc
oligodendrocyt
dysfunct
bernstein
et
al
also
upregul
liver
steatohepat
patient
tsutsumi
et
al
fetal
rabbit
lung
exposur
hyperox
condit
henschk
et
al
pancreat
bcell
ethanol
intox
lee
et
al
cardiac
cell
ischemichypox
precondit
muraguchi
et
al
chronic
restraint
stress
cytoprotect
respons
involv
transloc
nucleu
cytoplasm
mitochondria
pancreat
bcell
lee
et
al
retina
retin
epithelium
lee
et
al
ovarian
granulosa
cell
chowdhuri
et
al
figur
sripathi
et
al
suggest
local
traffick
phb
determin
modul
bind
specif
lipid
inde
strong
bind
cardiolipin
shown
correl
local
within
mitochondria
transform
epitheli
cell
oxid
stress
contrast
normal
condit
cell
bind
strongli
cardiolipin
overexpress
protect
pancreat
bcell
ovarian
granulosa
cell
cardiomyocyt
apoptosi
induc
ethanol
ceramid
staurosporin
serum
withdraw
oxid
stressinduc
injuri
consist
cytoprotect
role
chowdhuri
et
al
lee
et
al
liu
et
al
merkwirth
et
al
recent
describ
critic
role
surviv
neuron
neuronspecif
delet
mous
forebrain
impair
mitochondri
architectur
lead
tau
hyperphosphoryl
filament
format
phenotyp
accompani
sever
behavior
cognit
dysfunct
reminisc
alzheim
diseas
detail
mechan
cytoprotect
remain
poorli
document
actor
identifi
involv
protect
heart
ischemiareperfus
damag
directli
activ
therebi
regul
respir
cytochrom
oxidas
subunit
iv
assembl
decreas
heart
suscept
open
permeabl
transit
pore
ptp
gomez
et
al
increas
level
phosphoryl
transcript
factor
promot
surviv
intestin
cell
cardiomyocyt
gratia
et
al
theiss
et
al
intestin
epitheli
cell
vivo
interact
modul
apoptosi
kathiria
et
al
cardiomyocyt
upregul
central
cardioprotect
effect
oxid
stress
gratia
et
al
importantli
phosphoryl
protect
cardiomyocyt
oxid
stress
stimul
respir
inhibit
ptp
within
mitochondria
transcript
effect
boengler
et
al
would
interest
determin
whether
modul
mitochondri
action
inflammatori
bowel
diseas
ibd
character
strong
oxid
stress
associ
downregul
antioxid
enzym
intestin
mucosa
lihbrodi
et
al
sever
studi
vitro
vivo
indic
allevi
intestin
inflamm
promot
surviv
cell
expos
oxid
stress
intestin
epitheli
cell
bind
salmonella
typhi
antigen
inhibit
inflammatori
respons
typhi
infect
sharma
qadri
express
abnorm
low
ulcer
coliti
crohn
diseas
two
common
form
ibd
hsieh
et
al
theiss
et
al
yeo
et
al
due
overstimul
tumor
necrosi
factor
tnfa
signal
inflam
colon
theiss
et
al
downregul
increas
ro
signal
tnfainduc
autophagi
promot
inflamm
patient
ibd
kathiria
et
al
interestingli
transgen
mice
overexpress
intestin
epitheli
cell
exhibit
reduc
proinflammatori
nuclear
factor
kb
nfkb
signal
colon
mucosa
treatment
tnfa
demonstr
play
critic
role
inflamm
detail
examin
mechan
action
reveal
inhibit
tnfainduc
transloc
nfkb
downregul
express
importin
protein
involv
nfkb
nuclear
import
theiss
et
al
vivo
model
ibd
transgen
mice
exhibit
lower
oxid
stress
coliti
wildtyp
mice
theiss
et
al
cytoprotect
effect
due
upregul
nuclear
factor
erythroid
factor
transcript
activ
review
antioxid
respons
evid
put
therapeut
target
treat
ibd
come
observ
adenovirusdirect
administr
enema
nanoparticlebas
colon
deliveri
effect
enhanc
level
surfac
colon
epitheli
cell
allevi
coliti
induc
dextran
sodium
sulfat
theiss
et
al
picard
et
al
recent
demonstr
accumul
nucleu
osteoarthrit
chondrocyt
repress
express
transcript
factor
suggest
involv
etiolog
osteoarthr
addit
also
involv
inflamm
inde
heterozyg
shown
sensit
liver
insult
inflammatori
aggress
wildtyp
anim
confirm
cytoprotect
antiinflammatori
role
liver
nchezquil
et
al
luca
et
al
recent
discov
induc
immun
respons
b
cell
interact
phb
shown
induc
phosphoryl
ikba
phospholipas
protein
kinas
cab
ii
lead
nuclear
transloc
nfkb
nucleu
subsequ
transcript
and
mishra
and
et
al
establish
key
regul
insulin
signal
adipocyt
differenti
inde
directli
phosphoryl
insulin
receptor
promot
insulin
signal
block
akt
signal
wherea
phosphoryl
akt
opposit
effect
interestingli
phosphoryl
also
conjug
olink
bnacetylglucosamin
myoblast
cell
respons
insulin
high
glucos
glucoseinduc
oglcnac
modif
phosphoryl
may
associ
insulin
resist
modif
tyrosin
phosphoryl
phb
and
et
al
gu
et
al
inhibit
pyruv
carboxylas
decreas
insulinstimul
oxid
glucos
fatti
acid
adipocyt
impli
role
promot
lipid
accumul
vessal
et
al
crosslink
experi
show
associ
pyruv
carboxylas
ep
homolog
domain
protein
suggest
shuttl
extracellular
space
mitochondria
mechan
involv
lipid
raft
recent
and
et
al
demonstr
treatment
preadipocyt
insulin
peroxisom
proliferatoractiv
receptor
g
pparg
agonist
upregul
therebi
promot
preadipocyt
differenti
adipocyt
remark
overexpress
suffici
induc
adipogenesi
cell
surfac
also
marker
adipos
vasculatur
may
possibl
therapeut
target
obes
see
sever
recent
studi
demonstr
intern
virus
involv
phb
instanc
interact
chikungunya
viru
wintachai
et
al
interact
dengu
viru
kuadkitkan
et
al
interact
sever
acut
respiratori
syndrom
coronaviru
sarscov
cornillezti
et
al
also
interact
glycoprotein
promot
replic
spread
nonpermiss
cell
emerson
et
al
interestingli
recombin
capsid
protein
footandmouth
diseas
viru
dephosphoryl
akt
phosphophb
lipid
raft
downregul
craferk
signal
inhibit
metastasi
cancer
cell
vitro
vivo
chiu
et
al
moreov
use
highthroughput
mass
spectrometri
jang
et
al
discov
lipoteicho
acid
major
virul
factor
gramposit
bacteria
bind
implic
host
immun
respons
infect
activ
phb
affect
natur
product
eg
flavaglin
aurilid
fulli
synthet
small
molecul
eg
melanogenin
adipotid
chimer
peptid
current
phase
clinic
trial
compound
except
adipotid
examin
varieti
activ
becam
clear
phb
molecular
target
beststudi
phb
ligand
flavaglin
flavaglin
uniqu
cyclopenta
b
benzofuran
skeleton
ebada
et
al
ribeiro
et
al
rocaglamid
first
compound
describ
isol
year
ago
king
et
al
medicin
plant
genu
aglaia
meliacea
southeast
asia
sinc
flavaglin
includ
rocaglaol
silvestrol
identifi
figur
figur
see
also
tabl
although
flavaglin
display
myriad
pharmacolog
effect
due
anticanc
antiinflammatori
neuroprotect
cardioprotect
properti
anticanc
properti
attract
attent
scientist
ebada
et
al
ribeiro
et
al
concentr
lownanomolar
rang
flavaglin
inhibit
prolifer
tumor
cell
toxic
normal
cell
hausott
et
al
ribeiro
et
al
su
et
al
thuaud
et
al
thuaud
et
al
zhu
et
al
show
sign
toxic
mice
bernard
et
al
cencic
et
al
lee
et
al
thuaud
et
al
zhu
et
al
king
et
al
first
demonstr
antileukem
activ
rocaglamid
mous
model
subsequ
ohs
et
al
establish
flavaglin
strongli
inhibit
protein
synthesi
lee
et
al
demonstr
compound
delay
growth
human
breast
cancer
cell
athym
mice
howev
tumor
erad
investig
interrupt
sinc
develop
target
therapi
approach
develop
cytostat
compound
chang
radic
gutierrez
et
al
consequ
renew
interest
flavaglin
potenti
anticanc
agent
although
flavaglin
shown
signific
anticanc
effect
mous
model
cancer
alinari
et
al
cencic
et
al
hwang
et
al
king
et
al
lee
et
al
luca
et
al
meurergrim
et
al
thuaud
et
al
promis
potenti
associ
abil
enhanc
vivo
efficaci
anticanc
drug
particular
reliev
resist
tumor
chemotherapi
inde
flavaglin
shown
enhanc
doxorubicin
chemosensit
sever
mous
lymphoma
model
bordeleau
et
al
cencic
et
al
zhu
et
al
importantli
flavaglin
display
overt
sign
toxic
mice
studi
consist
previou
observ
recent
use
affin
chromatographycoupl
mass
spectrometri
polier
et
al
identifi
direct
target
flavaglin
bind
flavaglin
phb
inhibit
rascrafmekerk
signal
signal
essenti
surviv
cancer
cell
figur
craf
need
interact
phb
phosphoryl
ra
thu
particip
signal
rajalingam
et
al
bind
flavaglin
phb
prevent
interact
vitro
vivo
knockdown
either
small
interf
rna
sirna
mimick
effect
flavaglin
inhibit
capdepend
translat
arrest
cellcycl
progress
via
deplet
cyclin
moreov
rocaglamid
strongli
deplet
phosphoryl
craf
plasma
membran
suggest
reloc
phb
membran
involv
mode
action
flavaglin
variou
observ
support
idea
flavaglin
exert
anticanc
effect
action
phb
find
particular
interest
evid
rascraferk
constitut
overactiv
pathway
mani
human
cancer
pathway
promis
target
treatment
oncolog
matallana
et
al
maurer
et
al
bleumink
et
al
show
inhibit
craferk
signal
block
capdepend
protein
synthesi
inde
erk
activ
phosphoryl
allow
capdepend
synthesi
occur
protein
requir
phosphoryl
synthesi
involv
oncogenesi
angiogenesi
chemoresist
thu
vivo
anticanc
effect
flavaglin
seem
consequ
inhibit
synthesi
cyclin
cmyc
survivin
kinas
vascular
endotheli
growth
factor
vegf
matrix
metallopeptidas
bordeleau
et
al
cencic
et
al
nasr
et
al
polier
et
al
schatz
et
al
although
inhibit
rascraferk
signal
pathway
may
involv
flavaglineinduc
suppress
capdepend
synthesi
cell
bleumink
et
al
difficult
explain
observ
inhibit
protein
synthesi
vitro
craf
mek
erk
absent
observ
suggest
either
anoth
molecular
target
involv
inhibit
translat
flavaglin
phb
interact
translat
machineri
control
activ
flavaglin
induc
apoptosi
cancer
cell
myriad
mechan
ribeiro
et
al
involv
cytochrom
c
mi
et
al
zhu
et
al
apoptosisinduc
factor
thuaud
et
al
caspas
thuaud
et
al
mapk
jnk
zhu
et
al
zhu
et
al
whether
mechan
involv
anoth
target
remain
determin
effect
flavaglin
phbsinteract
protein
craf
also
issu
need
examin
silvestrol
flavaglin
studi
vivo
anticanc
properti
alinari
et
al
bordeleau
et
al
cencic
et
al
hwang
et
al
kim
et
al
mi
et
al
robert
et
al
schatz
et
al
howev
develop
compound
sever
limit
sensit
pglycoproteinmedi
multidrug
resist
suboptim
absorpt
distribut
metabol
excret
adm
characterist
gupta
et
al
liu
et
al
fortun
structureact
relationship
sar
chander
et
al
fusaro
et
al
joshi
et
al
interact
tumor
suppressor
rb
repress
transcript
inhibit
cell
prolifer
wang
et
al
wang
et
al
wang
et
al
repress
dna
replic
interact
compon
mammalian
replic
machineri
rizwani
et
al
protumorigen
role
phb
review
studi
establish
delet
methyl
ester
amid
posit
result
compound
escap
multidrug
resist
without
loss
cytotox
figur
ribeiro
et
al
thuaud
et
al
thuaud
et
al
addit
anticanc
effect
flavaglin
also
display
potent
antiinflammatori
neuroprotect
activ
inde
flavaglin
nanomolar
concentr
act
immunosuppressor
inhibit
product
interferong
tnfa
lymphocyt
proksch
et
al
immunosuppress
mediat
activ
mapk
jnk
select
inactiv
nuclear
factor
activ
cell
nfat
figur
still
known
flavaglin
activ
jnk
higher
concentr
flavaglin
also
inhibit
nfkb
anoth
transcript
factor
involv
inflamm
baumann
et
al
interestingli
synthet
flavaglin
inhibit
nfkb
signal
display
potent
vitro
antiinflammatori
effect
manifest
inhibit
figur
illustr
transloc
mitochondria
noncancer
cell
promot
surviv
proinflammatori
mediat
releas
astrocyt
microglia
endotheli
cell
fahrig
et
al
figur
importantli
protect
dopaminerg
neuron
vitro
vivo
model
parkinson
diseas
mpp
induc
neurotox
traumat
brain
injuri
recent
sar
studi
led
identif
provid
greater
neuroprotect
vitro
ribeiro
et
al
neuroprotect
activ
flavaglin
current
activ
explor
pharmaceut
compani
interm
discoveri
develop
figur
treatment
parkinson
diseas
studi
prompt
evalu
cytoprotect
potenti
flavaglin
tissu
synthet
flavaglin
figur
display
potent
cytotox
cancer
cell
thuaud
et
al
shown
protect
cardiomyocyt
vitro
vivo
variou
stress
includ
anthracyclin
cardiotox
bernard
et
al
heart
extrem
sensit
toxic
anthracyclin
doxorubicin
medicin
among
effect
anticanc
drug
avail
antitumor
activ
hematopoiet
solid
tumor
unfortun
clinic
util
markedli
hamper
cardiotox
lead
dilat
cardiomyopathi
congest
heart
failur
minotti
et
al
protect
cardiomyocyt
apoptosi
induc
doxorubicin
serum
starvat
bernard
et
al
interestingli
stress
differ
natur
doxorubicin
caus
oxid
stress
wherea
serum
starvat
block
growth
factor
signal
necessari
cell
surviv
mimick
import
compon
myocardi
ischemia
treatment
significantli
reduc
mortal
attenu
apoptosi
fibrosi
heart
doxorubicintr
mice
thu
flavaglin
may
enhanc
anticanc
efficaci
anthracyclin
allevi
main
advers
effect
cardiotox
anthracyclin
central
cancer
chemotherapi
discoveri
new
class
cardioprotect
agent
would
extrem
valuabl
clinic
studi
examin
therapeut
applic
therefor
warrant
cardioprotect
effect
flavaglin
mediat
phosphoryl
small
heat
shock
protein
figur
critic
protect
cell
mani
type
damag
includ
cardiotox
doxorubicin
exert
effect
sever
way
includ
chaperon
activ
control
redox
homeostasi
inhibit
apoptosi
kostenko
moen
whether
phb
anoth
target
involv
cardioprotect
effect
flavaglin
examin
although
cytoprotect
antiinflammatori
effect
flavaglin
yet
demonstr
mediat
bind
phb
unlik
anoth
target
involv
inde
pharmacolog
effect
cytotox
cancer
cell
occur
rang
concentr
far
know
natur
product
possess
complex
threedimension
structur
shown
bind
differ
class
protein
compar
high
affin
would
use
evalu
therapeut
applic
flavaglin
elucid
mechan
involv
may
seem
odd
anticanc
drug
also
display
variou
cardioor
neuroprotect
effect
howev
preced
exampl
rapamycin
deriv
erlich
et
al
khan
et
al
malagelada
et
al
hdac
inhibitor
cardioand
neuroprotect
addit
anticanc
effect
bush
mckinsey
mai
et
al
first
clue
understand
paradox
may
local
mainli
mitochondria
normal
cell
nucleu
cancer
cell
transloc
nucleu
cytosol
mitochondria
promot
surviv
normal
cell
apoptosi
cancer
cell
fusaro
et
al
therefor
tempt
suggest
opposit
behavior
flavaglin
cancer
normal
cell
consequ
differ
intracellular
local
phb
although
mani
academ
studi
demonstr
therapeut
potenti
flavaglin
preclin
model
cancer
inflammatori
cardiac
diseas
compound
yet
examin
clinic
trial
knowledg
two
pharmaceut
compani
interm
discoveri
infin
pharmaceut
current
develop
flavaglin
treatment
parkinson
diseas
cancer
respect
aurilid
isol
japanes
sea
hare
dolabella
auricularia
suenaga
et
al
suenaga
et
al
aurilid
cyclic
depsipeptid
display
strong
cytotox
nanomolar
subnanomolar
concentr
panel
cancer
cell
line
figur
figur
work
involv
affin
chromatographi
identifi
molecular
target
aurilid
sato
et
al
bind
toxin
activ
proteolyt
process
dynaminlik
gtpase
optic
atrophi
turn
trigger
remodel
mitochondri
crista
lead
apoptosi
devast
effect
mitochondria
probabl
explain
extrem
toxic
compound
imped
studi
anim
model
preclud
develop
medica
quest
identifi
compound
modul
skin
pigment
snyder
et
al
screen
taggedtriazin
librari
unpig
melanocyt
figur
figur
identifi
melanogenin
induc
pigment
ec
mm
compound
upregul
tyrosinas
ratelimit
enzym
biosynthesi
melanin
snyder
et
al
conjug
melanogenin
agaros
support
enabl
identifi
molecular
target
affin
chromatographi
biolog
investig
confirm
respons
induct
pigment
immunofluoresc
microscopi
studi
show
local
mitochondria
led
author
suggest
bind
melanogenin
may
disrupt
interact
transcript
factor
therebi
caus
transloc
nucleu
induct
express
tyrosinas
ratelimit
enzym
melanogenesi
studi
first
demonstr
unravel
involv
regul
mammalian
pigment
although
discoveri
may
provid
basi
develop
novel
cosmet
drug
treatment
pigment
disord
investig
direct
report
recent
wu
wu
demonstr
enrich
lipid
raft
hacat
keratinocyt
uvb
irradi
protect
cell
uvbinduc
apoptosi
find
consist
notion
contribut
protect
skin
uvb
adipotid
kolonin
et
al
staquicini
et
al
use
phage
display
techniqu
identifi
peptid
homolog
region
annexin
target
surfac
vascular
endotheli
cell
white
adipos
tissu
figur
fusion
proapoptot
sequenc
obtain
adipotid
ckggrakdcggd
klaklak
chimer
peptid
damag
vasculatur
adipos
tissu
consequ
disrupt
blood
suppli
adipocyt
obes
mice
adipotid
induc
substanti
loss
weight
normal
metabol
lead
revers
obes
without
advers
sign
toxic
surprisingli
food
intak
reduc
suggest
unexpect
relationship
adipos
tissu
vasculatur
regul
feed
behavior
kim
et
al
obes
rhesu
monkey
week
adipotid
treatment
led
reduct
bodi
fat
also
reduc
food
intak
improv
anim
metabol
statu
ie
reduc
insulin
resist
find
implic
develop
treatment
type
diabet
barnhart
et
al
adipotid
current
develop
biotech
compani
arrowhead
research
corpor
enter
phase
trial
involv
obes
patient
prostat
cancer
juli
adipotid
neg
endocrin
effect
tumor
growth
expect
slow
tumor
growth
patient
capsaicin
compon
hot
chili
pepper
inhibit
prolifer
mani
cancer
cell
line
use
affin
chromatographi
fletcher
et
al
demonstr
capsaicin
mm
bind
bind
induc
seri
proapoptot
event
human
myeloid
leukemia
cell
includ
transloc
mitochondria
nucleu
dissoci
adenin
nucleotid
transloc
lead
noncompetit
inhibit
ant
activ
releas
cytochrom
c
cytosol
figur
latter
two
effect
could
caus
deplet
mitochondria
would
compromis
mitochondri
integr
promot
apoptosi
capsaicin
use
experi
concentr
much
high
therapeut
relev
work
may
constitut
basi
optim
program
develop
clinic
use
drug
sulfonyl
amidin
deriv
sulfonyl
amidin
inhibit
osteoclastogenesi
involv
bone
remodel
ic
mm
lee
et
al
figur
chang
et
al
use
affin
chromatographi
identifi
molecular
target
involv
process
found
aurilid
cytotox
depsipeptid
bind
trigger
remodel
mitochondri
crista
lead
apoptosi
b
melanogenin
bind
induc
express
tyrosinas
ratelimit
enzym
melanogenesi
c
adipotid
chimer
peptid
target
surfac
vascular
endotheli
cell
white
adipos
tissu
proapoptot
sequenc
respons
damag
tissu
bind
capsaicin
induc
transloc
mitochondria
nucleu
noncompetit
inhibit
releas
cytochrom
c
cytosol
lead
apoptosi
myeloid
leukemia
cell
e
sulfonyl
amidin
inhibit
osteoclastogenesi
involv
bone
remodel
compound
bind
three
protein
protein
relev
target
involv
antiresorpt
activ
remain
unknown
f
bind
mitofilin
promot
neuron
product
neurotox
peptid
involv
etiolog
alzheim
diseas
g
dihydrooxazol
choxa
alkyl
suggest
could
use
chemic
probe
analyz
structur
compound
bind
three
protein
protein
relev
target
involv
antiresorpt
activ
remain
determin
investig
toxic
peptid
produc
alzheim
diseas
bettayeb
et
al
observ
adenin
deriv
promot
product
neuron
figur
found
interact
three
protein
relat
neural
degener
voltagedepend
anion
channel
mitofilin
choxa
dihydrooxazol
choxa
display
cytotox
gi
mm
cell
shown
alkyl
suggest
could
use
chemic
probe
analyz
structur
trzeciakiewicz
et
al
figur
regul
phb
cell
surviv
apoptosi
metabol
inflamm
make
protein
promis
therapeut
target
novel
treatment
cancer
neurodegen
metabol
inflammatori
diseas
intracellular
local
transloc
respons
proapoptot
signal
differ
substanti
normal
cancer
cell
diverg
behavior
fulli
understood
may
exploit
develop
therapeut
agent
phase
trial
adipotid
treatment
obes
patient
prostat
cancer
may
first
step
road
develop
phb
ligand
clinic
valu
recent
discoveri
flavaglin
target
phb
warrant
studi
class
anticanc
cytoprotect
agent
addit
ongo
explor
role
phb
physiolog
physiopatholog
anticip
field
stimul
research
address
class
phb
ligand
origin
pharmacolog
properti
last
year
phb
found
interact
protein
regul
myriad
cellular
event
doubt
come
year
new
partner
new
cellular
regul
uncov
import
issu
determin
alter
phb
express
subcellular
local
signal
involv
etiolog
cancer
also
cardiac
neurolog
inflammatori
metabol
diseas
translat
knowledg
clinic
applic
may
lead
develop
new
medicin
biomark
diagnosi
prognosi
supplement
inform
includ
five
figur
one
tabl
found
articl
onlin
http
